IFNA1 and breast cancer: In order to further validate our preclinical findings, we used single cell RNAseq data from a cohort of breast cancer patients treated with anti-PD-125, which confirmed that inflammatory tumour-infiltrating monocytes were mainly responsible for the on/fast-off IFN signal in these patients, and that enrichment of these cells was correlated with T cell expansion.